![](/images/graphics-bg.png)
Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hyperferritinemia
Joint Authors
Shahrbanoo, Keyhanian
Taziki, Omolbanin
Source
Saudi Journal of Kidney Diseases and Transplantation
Issue
Vol. 19, Issue 6 (31 Dec. 2008), pp.933-936, 4 p.
Publisher
Saudi Center for Organ Transplantation
Publication Date
2008-12-31
Country of Publication
Saudi Arabia
No. of Pages
4
Main Subjects
Topics
Abstract EN
Hemodialysis (HD) patients with functional iron deficiency (FID) often develop resistance to recombinant human erythropoietin (Epo).
The contributory role of chronic inflammation and oxidative stress in its pathogenesis is poorly understood.
We assessed the effect of vitamin C, an antioxidant, on Epo-hyporesponsive anemia in hemodialysis patients with unexplained hyperferritinemia levels.
Thirty-one of 132 with Hb < 11 g / dL were prospectively followed up after exclusion of reasons for Epo hyporesponsiveness.
Patients were randomly divided into two groups: 15 patients received standard care and 300 mg of intravenous vitamin C with each dialysis session (group 1) and 15 patients received standard care (group 2).
After 3 months, Hb and transferrin saturation levels significantly increased in group 1 but not in group 2 (p < 0.05%).
Hemoglobin content in reticulocyte and serum ferritin decreased significantly in group 1 but not in control group.
In conclusion, hemodialysis patients with refractory anemia and adequate iron stores, vitamin C improved responsiveness to Epo by augmenting iron mobilization and possibly via antioxidant effect.
American Psychological Association (APA)
Shahrbanoo, Keyhanian& Taziki, Omolbanin. 2008. Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hyperferritinemia. Saudi Journal of Kidney Diseases and Transplantation،Vol. 19, no. 6, pp.933-936.
https://search.emarefa.net/detail/BIM-40142
Modern Language Association (MLA)
Shahrbanoo, Keyhanian& Taziki, Omolbanin. Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hyperferritinemia. Saudi Journal of Kidney Diseases and Transplantation Vol. 19, no. 6 (Dec. 2008), pp.933-936.
https://search.emarefa.net/detail/BIM-40142
American Medical Association (AMA)
Shahrbanoo, Keyhanian& Taziki, Omolbanin. Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hyperferritinemia. Saudi Journal of Kidney Diseases and Transplantation. 2008. Vol. 19, no. 6, pp.933-936.
https://search.emarefa.net/detail/BIM-40142
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 935-936
Record ID
BIM-40142